Core Viewpoint - Corning Jereh Pharmaceutical-B (09966.HK) repurchased 400,000 shares on October 16, 2025, at a total cost of HKD 5.483 million, indicating a strategic move to enhance shareholder value [1][2]. Group 1: Share Buyback Details - The company repurchased shares at prices ranging from HKD 13.520 to HKD 13.820 per share [1]. - The closing price on the day of the buyback was HKD 13.700, reflecting a 2.54% increase in share price [1]. - The total trading volume for the day was HKD 35.6313 million [1]. Group 2: Year-to-Date Buyback Summary - Year-to-date, the company has conducted three buyback transactions, totaling 801,000 shares repurchased [2]. - The cumulative amount spent on buybacks this year is HKD 10.9358 million [2]. - Detailed buyback transactions include: - October 16: 400,000 shares at a maximum price of HKD 13.820 and a minimum price of HKD 13.520, costing HKD 5.483 million [2]. - October 14: 293,000 shares at a maximum price of HKD 13.830 and a minimum price of HKD 13.030, costing HKD 3.9669 million [2]. - October 13: 108,000 shares at a maximum price of HKD 13.800 and a minimum price of HKD 13.690, costing HKD 1.4860 million [2].
康宁杰瑞制药-B(09966.HK)10月16日回购40.00万股，耗资548.30万港元